Blogs & Videos | BenevolentAI

Type

Subject

Search

105 results found

Keynote Panel: The benefits of AI within drug discovery

CSO, Anne Phelan talks to Emerj about the challenges of drug discovery and how AI can be used to tackle this

Dr Francois Nader • 42nd Annual J.P. Morgan Healthcare Conference

Sano Genetics & BenevolentAI: Combining machine learning with genetic and medical data in ulcerative colitis

BenevolentAI’s CSO, Anne Phelan, recognised for her contributions to innovation in drug development

BenevolentAI’s approach to AI-enabled drug discovery

AI Adoption in the UK

link23 launch: The power of partnerships in improving equity in genomics

Leveraging-Single-Cell-Data-In-Our-Drug-Discovery-Platform.jpg

Leveraging single cell data in our drug discovery Platform

Data & digital innovation for climate and health | Wellcome

JPM--BenevolentAI--Company-Overview-by-Joanna-Shields-CEO.jpeg

BenevolentAI: Company Overview by Joanna Shields, CEO

FAIR_Data_Foundation__An_Enabler_for_AI_Drug_Discovery.jpg

FAIR Data Foundation: An Enabler For AI Drug Discovery

GlobalBiotechRevolution: The Quantified Self

Building_the_data_foundations_to_accelerate_drug_discovery.jpg

Building The Data Foundations To Accelerate Drug Discovery

Text-_-Data-Mining-In-Drug-Discovery--A-Conversation-With-Springer-Nature.jpg

Text & Data Mining In Drug Discovery: A Conversation With Springer Nature

Innovation-Week--pushing-the-boundaries-of-AI-in-drug-discovery.jpg

Innovation Week: pushing the boundaries of AI in drug discovery

Fueling Continuous Innovation At BenevolentAI

WEF22-_-Unlocking-the-Power-of-Digital-Health-w--Joanna-Shields-_-Davos.jpeg

#WEF22 | Unlocking the Power of Digital Health w/ Joanna Shields | Davos

FDA Converts Emergency Approval Of Baricitinib — First Identified As A COVID Treatment By BenevolentAI — To A Full Approval

How-AI-Machine-Learning--Big-Data-Are-Disrupting-The-Drug-Discovery--Development-Landscape.jpeg

How AI, Machine Learning & Big Data Are Disrupting The Drug Discovery & Development Landscape

BenevolentAI · AI-Enabled Drug Discovery

Please Don’t Use This Sentence Out Of Context

Joanna-Shields-J.P.-Morgan-Health-Care-Conference-2022.jpg

Joanna Shields • J.P. Morgan Health Care Conference 2022

World Health Organization Panel Strongly Recommends The Use Of Baricitinib To Treat Hospitalised Patients With COVID-19

It’s Up To Us: Reflections On Responsible Innovation

Measuring Bias: Moving Towards More Inclusive Health Research Outcomes #Stateofai

Expert-Augmented Computational Drug Discovery For Rare Diseases

Spark for ML data preprocessing

AI In Drug Discovery

Product Design In AI-Drug Discovery: How To Design Products For And With Scientific Users

A-New-Era-in-Target-Discovery--Collaborating-with-AstraZeneca-on-CKD-and-IPF.jpg

A New Era in Target Discovery: Collaborating with AstraZeneca on CKD and IPF

How_to_use_Makefiles_to_run_a_simple_Map_Reduce_Data_Pipeline.jpg

How to use Makefiles to run a simple Map Reduce Data Pipeline

ACTT-2_trial_results_published_in_the_New_England_Journal_of_Medicine_validate_baricitinibs_efficacy_in_combination_with_remdesivir_in_hospitalised_COVID-19_patients.jpg

ACTT-2 Trial Results Published In The New England Journal Of Medicine Validate Baricitinib’s Efficacy In Combination With Remdesivir In Hospitalised COVID-19 Patients

Joanna Shields Speaks At The Global Partnership On Artificial Intelligence

Data_Published_In_Science_Advances_Shows_Baricitinib_Reduces_COVID-19_Morbidity_And_Mortality.jpg

Data Published In Science Advances Shows Baricitinib Reduces COVID-19 Morbidity And Mortality

BenevolentAI wins Innovation Award at 2020 Scrip Awards

API design for cross-team collaboration

Data_Diversity__Ten_practical_approaches_to_acquire_the_right_datasets_Part_2.jpg

Data Diversity: Ten Practical Approaches To Acquire The Right Datasets Part 2

Data_Diversity__Ten_practical_approaches_to_acquiring_the_right_datasets_Part_1.jpg

Data Diversity: Ten Practical Approaches To Acquiring The Right Datasets Part 1

The_Diversity_Analysis_Tool_DAT__Towards_better_Diversity_in_Data_for_Precision_Medicine.jpg

The Diversity Analysis Tool (DAT): Towards Better Diversity In Data For Precision Medicine

Spark on Kubernetes for NLP at scale

Deploying MetalLB In Production

How-do-we-get-the-next-10-years-right--w--Joanna-Shields-CogX.jpg

How Do We Get The Next 10 Years Right? W/ Joanna Shields, CogX

It Takes Two: The Benefits Of Pair Working

Future-Fifty--Joining-Forces-To-Drive-Forward-Positive-Change.jpeg

Future Fifty: joining forces to drive forward positive change

Challenges-of-designing-an-AI-platform-for-Drug-Discovery-w--Marek-Kultys.jpg

Challenges of designing an AI platform for Drug Discovery w/ Marek Kultys

Medical_Data__The_Key_To_Unlocking_The_True_Potential_Of_AI_In_Healthcare.jpg

Medical data: the key to unlocking the true potential of AI in healthcare

Teaming_Up_To_Fuel_Scientific_Discovery_In_CCM_Research.jpg

Teaming up to fuel scientific discovery in CCM research

Data-Diversity-Initiative--Tackling-the-Medical-Research-Data-Gap.jpg

Data Diversity Initiative: Tackling the Medical Research Data Gap

Charting-the-progress-of-BenevolentAIs-collaboration-with-AstraZeneca.jpg

Charting The Progress Of BenevolentAI’s Collaboration With AstraZeneca

Digital-Economy--The-digitisation-of-healthcare-w--Jackie-Hunter.jpeg

Digital Economy: The digitisation of healthcare w/ Jackie Hunter

Mind_The_Gap__The_Diversity_Issue_In_Medical_Research_.jpg

Mind the gap: the diversity issue in medical research.

Jackie Hunter discusses defining innovation

Our-team-behind-the-scenes-at-SXSW-_-Next-steps--From-molecule-design-to-medicine.jpg

Our Team Behind The Scenes At SXSW | Next Steps: From Molecule Design To Medicine

Our-team-behind-the-scenes-at-SXSW-_-Opening-by-Joanna-Shields-BenevolentAI-CEO.jpg

Our Team Behind The Scenes At SXSW | Opening By Joanna Shields, BenevolentAI CEO

Our-team-behind-the-scenes-at-SXSW-_-Patient-Stratification-in-Target-ID-OMICS-data.jpg

Our Team Behind The Scenes At SXSW | Patient Stratification In Target ID, OMICS Data

Our-team-behind-the-scenes-at-SXSW-_-Target-Identification-Literature-Knowledge-Inference.jpg

Our Team Behind The Scenes At SXSW | Target Identification, Literature Knowledge Inference

Our-team-behind-the-scenes-at-SXSW-_-Building-a-Disease-Specific-Knowledge-Base.jpg

Our Team Behind The Scenes At SXSW | Building A Disease Specific Knowledge Base

The_promise_of_using_AI_for_target_identification_and_working_with_AstraZeneca.jpg

The promise of using AI for target identification and working with AstraZeneca

Using-Artificial-Intelligence-in-Drug-Discovery-with-Jackie-Hunter.jpg

Using Artificial Intelligence In Drug Discovery w/ Jackie Hunter

New Strategic Partnership with AstraZeneca

The-Future-of-AI-in-Drug-Discovery--How-Artificial-Intelligence-is-Generating-Ideas-for-New-Medicines.jpg

The Future of AI in Drug Discovery: How Artificial Intelligence is Generating Ideas for New Medicines

AI: The Next Revolution In Medicine?

Advancing_Oncology_Drug_Development_With_Precision_Medicine.jpg

Advancing Oncology Drug Development with Precision Medicine

Why we need to use AI for life, not just lifestyle

Joanna-Shields-talks-to-CNN-about-the-power-of-AI-in-healthcare.jpg

Joanna Shields talks to CNN about the power of AI in healthcare

Research blog

Research_Blog_Thumbnails__Improving_entity_linking_in_biomedical_text_analyses.jpg

Improving entity linking in biomedical text analyses

Research_Blog_Thumbnails__Language_modelling_of_electronic_health_record_data.jpg

Language modelling of electronic health record data

BenevolentResearch-On-Masked-Language-Models-for-Contextual-Link-Prediction.jpg

On Masked Language Models for Contextual Link Prediction

BenevolentResearch-Improving-data-integration-counterfactual-inference-_-fairness-ICML-2022.jpg

Improving data integration, counterfactual inference & fairness · ICML 2022

Research_Blog_Thumbnails__Improving_data_integration_counterfactual_inference_and_fairness.jpg

Improving data integration, counterfactual inference and fairness

Research_Blog_Thumbnails__Can_masked_language_modelling_beat_knowledge_graph_methods_for_contextual_link_prediction-.jpg

Can masked language modelling beat knowledge graph methods for contextual link prediction?

Research_Blog_Thumbnails__Using_de_novo_molecular_design_methods_to_discover_novel_medicines.jpg

Using de novo molecular design methods to discover novel medicines.

BenevolentResearch--Directed-Graph-Embeddings-in-Pseudo-Riemannian-Manifolds.jpg

Directed Graph Embeddings in Pseudo-Riemannian Manifolds

Research_Blog_Thumbnails__Inferring_causal_networks_from_the_correlated_tangle_of_gene_expression_data.jpg

Inferring causal networks from the correlated tangle of gene expression data to paint detailed molecular descriptions of disease mechanisms.

Research_Blog_Thumbnails__BenevolentAI_at_NeurIPS_2020-_Machine_Learning_in_Drug_Discovery.jpg

BenevolentAI at NeurIPS 2020: Machine Learning in Drug Discovery

Research_Blog_Thumbnails__Use_of_machine_learning_in_the_diagnosis_and_treatment_of_neurodegenerative_diseases.jpg

Use of machine learning in the diagnosis and treatment of neurodegenerative diseases

Research_Blog_Thumbnails__Introducing_our_latest_research_at_NeurIPS2019.jpg

Introducing our latest research at NeurIPS2019

Research_Blog_Thumbnails__Research-_Biomedical_relation_extraction_BERT.jpg

Research: Biomedical relation extraction (BERT)

Research_Blog_Thumbnails__New_biomedical_relation_extraction_model_with_pre-trained_language_representations.jpg

New biomedical relation extraction model with pre-trained language representations and minimal task-specific architecture

Research_Blog_Thumbnails__Interpret_-_Constructing_large_scale_biomedical_knowledge_bases_from_scratch.jpg

Interpret - Constructing large scale biomedical knowledge bases from scratch

Research_Blog_Thumbnails__Extracting_existing_facts_without_requiring_any_training_data_or_hand-crafted_rules.jpg

Extracting existing facts without requiring any training data or hand-crafted rules

Research_Blog_Thumbnails__BenevolentAI_has_released_GuacaMol_a_framework_to_benchmark_models_for_de_novo_molecular_design.jpg

GuacaMol, a new framework to compare models for de novo molecular design

Sign up for our news